Fundraising FoxNan Fung Life Sciences
Family officeHong Kong · Seed–Growth · 1 people tracked
Find your way into Nan Fung Life Sciences
Team · 1 people
from public directoriesWhat they invest in
from 5 of 6 portfolio companiesBiotech ×5Healthtech ×2Longevity ×1Medical Devices ×1
HQs:United States×5
Investments · 7 tracked
founders shown can be your intro pathBy year:2022 · 12021 · 12020 · 12019 · 14 dated
Bolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer.
BiotechHealthtechMedical DevicesSan Francisco, US
Dr. Edgar G. Engleman(Founder)
Co-investorsPfizer Venture InvestmentsPivotal Life SciencesRA CapitalSamsara BioCapitalSofinnova VenturesVivo Capital+3 more
BiotechEvanston, US
Joseph R. Moskal(Chief Scientific Officer)Torsten M. Madsen(Chief Marketing Officer)Ashish Khanna(Secretary & Chief Business Officer)Norbert G. Riedel(Chief Executive Officer)
BoardLiam Ratcliffe(Director)Terry P. Gould(Director)
Co-investorsBain Capital Life SciencesFrazier Life SciencesLatterell Venture PartnersLongitude CapitalOUP (Osage University Partners)Agent Capital+3 more
Eargo was a hearing aid company that provided high-quality hearing aids and related care services.
HealthtechMedical DevicesMountain View, US
Raphael Michel(Executive Officer, Director)Christian Gormsen(Executive Officer, Director)William Brownie(Executive Officer)Peter Tuxen Bisgaard(Director)
BoardDavid Wu(Director)inJosh Makower(Director)
Co-investorsBirchmere VenturesDolby Family VenturesLongitude CapitalMaveronNew Enterprise Associates (NEA)Crosslink Capital+3 more
San Diego protein-sequencing company behind the ProteoCode platform; ceased operations in late 2025.
Co-investorsARCH Venture PartnersDecheng CapitalAlexandriaDeerfield Management CompanyGV (Google Ventures)Northpond Ventures
Fountain is a biotech company developing first-in-class therapies for diseases and conditions caused by aging, using in vitro and in vivo screening platforms to identify drug candidates.
BiotechHealthtechLongevitySan Francisco, US
Thomas Rando(Co-founder)Joseph Rodgers(Co-founder)inTom Cheung(Co-founder)inTsang(Chief Business Officer)
Co-investorsAlexandriaKhosla VenturesR42 Group
San Diego DNA sequencing company behind the Sequencing by Binding short-read platform; acquired by Pacific Biosciences in 2021.
BiotechSan Diego, US
David S. Mullarkey(Executive Officer, Director)Arnold Oliphant(Executive Officer)inKen Song, M.D., Ph.D.(Executive Officer, Director)Kelly Perez(Executive Officer)John Murphy, Ph.D.(Executive Officer)Millard Y Chan(Chief Operating Officer, Secretary and Director)
Co-investorsARCH Venture PartnersDCVC (Data Collective)Decheng CapitalLam CapitalPivotal Life SciencesALTITUDE LIFE SCIENCE VENTURES+2 more
BiotechWaltham, US
Chrystiyna Bedrij(Director)Peter Bisgaard(Director)Vincent Cheung(Director)Laura Benjamin(Director)Benjamin Chen(Director)
Co-investorsK2 HealthVenturesPivotal bioVenture Partners ChinaVolcanics Venture
Exits · 2
1 IPOs · 1 acquisitions · showing 1Bolt BiotherapeuticsNASDAQ: BOLT
Frequently asked questions
- How many investments has Nan Fung Life Sciences made?
- Nan Fung Life Sciences has 6 tracked investments, 2 of which have exited.
- What stage does Nan Fung Life Sciences invest at?
- Nan Fung Life Sciences invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Nan Fung Life Sciences focus on?
- Nan Fung Life Sciences focuses on Biotech.
- Where is Nan Fung Life Sciences located?
- Nan Fung Life Sciences is headquartered in Hong Kong, HK.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.